Edwards Lifesciences Corp (EW) · Insider Trading (Form 4) SEC Filing

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-05-11 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Edwards Lifesciences Corp (EW) CIK: 0001099800 --- Reporting Owner --- Name: Ullem Scott B. CIK: 0001446989 Role: Officer (CVP, Chief Financial Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-05-11 | Code: M (Exercise of derivative) Shares: +19,830 | Price: $0.00 Shares Owned After: 57,744 | Ownership: D (Direct) Footnotes: [F1] On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4. [F1] On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4. [Transaction #2] Security: Common Stock Date: 2026-05-11 | Code: F (Payment of exercise/tax) Shares: -11,004 | Price: $79.96 Total Value: $879,879.84 Shares Owned After: 46,740 | Ownership: D (Direct) --- Derivative Transactions --- [Transaction #1] Security: Performance Rights Date: 2026-05-11 | Code: M (Exercise of derivative) Shares: -19,830 | Price: $0.00 Shares Owned After: 0 | Ownership: D (Direct) Footnotes: [F1] On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4. [F2] These Performance Rights expire on May 10, 2030. --- Holdings --- [Holding #1] Security: Common Stock Ownership: I (Indirect) --- Footnotes (Complete Index) --- F1: On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4. F2: These Performance Rights expire on May 10, 2030. --- Signature --- /s/ Linda J. Park, Attorney-in-Fact (2026-05-11)